A company called BioViva is getting calls from athletes, trainers, and coaches looking to use one of its gene therapies, says New Scientist. The company claims the experimental therapy blocks the breakdown of muscle tissue, which would be useful for athletes looking for more efficient ways to build muscle or keep their muscles from breaking down. And even though there's no clear evidence yet that the therapy does what it's supposed to do, the athletes keep calling.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.